Invention Grant
- Patent Title: Crystalline oxazine derivative
- Patent Title (中): 结晶恶嗪衍生物
-
Application No.: US13347067Application Date: 2012-01-10
-
Publication No.: US08524897B2Publication Date: 2013-09-03
- Inventor: Rita Ramos
- Applicant: Rita Ramos
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Joshua Roth
- Main IPC: C07D413/12
- IPC: C07D413/12
Abstract:
The invention relates to 5-cyano-3-methyl-pyridine-2-carboxylic acid [3-((3R,6R)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2H-[1,4]oxazin-3-yl)-4-fluoro-phenyl]-amide in crystalline form, to its preparation, its medical use and to medicaments comprising said compound in crystalline form.
Public/Granted literature
- US20120178745A1 Novel Crystalline Oxazine Derivative Public/Granted day:2012-07-12
Information query
